Palmar plantar erythrodysesthesia epidemiology and demographics: Difference between revisions
(Mahshid) |
No edit summary |
||
| (14 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Palmar plantar erythrodysesthesia}} | {{Palmar plantar erythrodysesthesia}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{MC}} | ||
==Overview== | ==Overview== | ||
Palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 - 64% of [[Patient|patients]] treated with different [[chemotherapy]] regimens. However, the exact [[incidence]] of PPE is unknown, as most reports are isolated [[Case report|case reports]] or short [[case series]]. | |||
==Epidemiology and Demographics== | |||
===Incidence=== | |||
* Based on some [[case series]], palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 - 64% of [[Patient|patients]] treated with different [[chemotherapy]] regimens. <ref>{{Cite journal | |||
| author = [[L. Hueso]], [[O. Sanmartin]], [[E. Nagore]], [[R. Botella-Estrada]], [[C. Requena]], [[B. Llombart]], [[C. Serra-Guillen]], [[A. Alfaro-Rubio]] & [[C. Guillen]] | |||
| title = [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases] | |||
| journal = [[Actas dermo-sifiliograficas]] | |||
| pmid = 18394404 | |||
}}</ref> | |||
==References== | ==References== | ||
{{reflist|3}} | {{reflist|3}} | ||
Latest revision as of 20:18, 17 July 2019
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia epidemiology and demographics |
|
FDA on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
CDC on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Palmar plantar erythrodysesthesia epidemiology and demographics in the news |
|
Blogs on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 - 64% of patients treated with different chemotherapy regimens. However, the exact incidence of PPE is unknown, as most reports are isolated case reports or short case series.
Epidemiology and Demographics
Incidence
- Based on some case series, palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 - 64% of patients treated with different chemotherapy regimens. [1]
References
- ↑ L. Hueso, O. Sanmartin, E. Nagore, R. Botella-Estrada, C. Requena, B. Llombart, C. Serra-Guillen, A. Alfaro-Rubio & C. Guillen. "[Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases]". Actas dermo-sifiliograficas. PMID 18394404.